(19)
(11) EP 1 169 042 A1

(12)

(43) Date of publication:
09.01.2002 Bulletin 2002/02

(21) Application number: 00911811.8

(22) Date of filing: 14.02.2000
(51) International Patent Classification (IPC)7A61K 31/551, A61K 31/553, A61K 31/554, A61P 9/10, A61P 19/08, C07D 223/18, C07D 243/10, C07D 243/38, C07D 267/12, C07D 273/06, C07D 281/02, C07D 285/36, C07D 291/08, C07D 471/02, C07D 471/12, C07D 487/02, C07D 487/12, C07D 498/02, C07D 498/12, C07D 513/02, C07D 513/12
(86) International application number:
PCT/US0003/796
(87) International publication number:
WO 0048/603 (24.08.2000 Gazette 2000/34)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 17.02.1999 US 120564 P

(71) Applicant: Merck & Co., Inc.
Rahway, New Jersey 07065-0907 (US)

(72) Inventors:
  • PATANE, Michael, A.
    Rahway, NJ 07065-0907 (US)
  • NEWTON, Randall, C.
    Rahway, NJ 07065-0907 (US)

(74) Representative: Thompson, John Dr. 
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR
Harlow, Essex CM20 2QR (GB)

   


(54) DIBENZO-AZEPINE DERIVATIVES AS ALPHA V INTEGRIN RECEPTOR ANTAGONISTS